TrialBlood2015

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.

Davide Rossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.